FDA Places Clinical Hold on Advaxis' (ADXS) Axalimogene Filolisbac IND Application

October 6, 2015 4:02 PM

Advaxis (NASDAQ: ADXS) announced that last Thursday the company received verbal notice from the U.S. Food and Drug Administration (FDA) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found